# Humanis Saglık Anonim Sirketi clinical trials: 42 (2026)

ClinicalTrials.gov lists 42 trials with Humanis Saglık Anonim Sirketi as lead sponsor, 0 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Humanis Saglık Anonim Sirketi: 42 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/humanis-sagl-k-anonim-sirketi

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 42
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 42, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 13, 2026 | NCT07872358 | Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM), Cardiovascular Diseases | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07872358) |
| July 9, 2026 | NCT07694128 | Bioequivalence Study to Compare Selexipag 400 Microgram Film Coated Tablets Versus Uptravi® (Selexipag) 400 Microgram Film Coated Tablets | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Arterial Hypertension (PAH) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07694128) |
| July 9, 2026 | NCT07694115 | Bioequivalence Study to Compare Empagliflozin/ Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07694115) |
| July 8, 2026 | NCT07691203 | Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCl 25 mg/5 mg/1000 mg Extended Release Tablet Versus Trijardy® XR 25... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM), Cardiovascular Diseases | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691203) |
| July 8, 2026 | NCT07691190 | Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | SCHIZOPHRENIA 1 (Disorder) | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691190) |
| July 8, 2026 | NCT07691177 | Bioequivalence Study to Compare Imeglimin HCl 500 mg Film Coated Tablets Versus Twymeeg Tablets 500 mg | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691177) |
| January 28, 2026 | NCT07372118 | Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM) | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07372118) |
| December 12, 2025 | NCT07278349 | Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Erosive Gastritis, Erosive Esophagitis(EE), HELICOBACTER PYLORI INFECTIONS | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07278349) |
| December 5, 2025 | NCT07266792 | Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet (Brexpiprazole) | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Schizophrenia | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07266792) |
| December 5, 2025 | NCT07266779 | Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Product (R) of... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07266779) |
| December 5, 2025 | NCT07266766 | Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07266766) |
| October 9, 2025 | NCT07213895 | Bioequivalence Study to Compare Empagliflozin/Linagliptin/Metformin HCL 25mg/5mg/1000mg Extended-Release Tablets Versus Trijardy® XR... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM) | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07213895) |
| September 12, 2025 | NCT07170852 | Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Hypercholesterolaemia | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07170852) |
| August 1, 2025 | NCT07098585 | To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, Hard... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Attention Deficit/Hyperactivity Disorder (ADHD) | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07098585) |
| June 29, 2025 | NCT07042828 | To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Allergic Rhino-Conjunctivitis, Urticaria | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07042828) |
| June 26, 2025 | NCT07039890 | To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07039890) |
| April 17, 2025 | NCT06932198 | Bioequivalence Study to Compare Selexipag 400mcg Film Coated Tablets (400 mcg Selexipag) Versus Uptravi® 400mcg Film Coated Tablets (400... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Pulmonary Arterial Hypertension (PAH) | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06932198) |
| April 17, 2025 | NCT06932159 | Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Type 2 Diabetes Mellitus (T2DM) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06932159) |
| April 16, 2025 | NCT06930937 | To Compare and Evaluate the Oral Bioavailability of Edoxaban 60 mg Film Coated Tablet With That of Lixiana® 60 mg Filmtabletten (Film... | Humanis Saglık Anonim Sirketi | Not applicable | Completed | Prevention of Stroke or Systemic Embolism, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06930937) |
| April 11, 2025 | NCT06923956 | Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Hypercholesterolaemia, Mixed Dyslipidaemia, Cardiovascular Diseases | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06923956) |
| April 10, 2025 | NCT06922253 | Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Valsartan) Tablets (97... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Chronic Heart Failure | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06922253) |
| September 19, 2024 | NCT06592300 | Bioequivalence Study of Two Products of Tenofovir Alafenamide 25 mg Film Tablet in Healthy, Adult, Human Subjects | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Chronic Hepatitis B in Adults and Paediatric Patients | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06592300) |
| August 16, 2024 | NCT06557603 | Bioequivalence Study of Ivermectin 1% Cream and Soolantra (Ivermectin) 10 mg/g Cream | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | Rosacea | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06557603) |
| August 14, 2024 | NCT06553937 | Bioequivalence Study of Macitentan and Tadalafil Film-coated Tablets 10 Mg/40 Mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated... | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | PAH | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06553937) |
| August 14, 2024 | NCT06553924 | Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg | Humanis Saglık Anonim Sirketi | Phase 1 | Completed | PAH | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06553924) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 38 |
| Phase 1/2 | 2 |
| Phase 3 | 1 |
| Not applicable | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 42 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Diabetes Mellitus, Type 2 | 10 |
| Cardiovascular Diseases | 3 |
| Pulmonary Arterial Hypertension | 3 |
| Hypercholesterolemia | 2 |
| Rhinitis, Allergic, Seasonal | 2 |
| Epilepsy | 2 |
| Rhinitis, Allergic, Perennial | 1 |
| Urticaria | 1 |
| Hypertension | 1 |
| HIV Infections | 1 |
| Xanthomatosis, Cerebrotendinous | 1 |
| Rosacea | 1 |
| Migraine Disorders | 1 |
| Headache | 1 |
| Back Pain | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Psoriasis | 1 |
| Arthritis, Psoriatic | 1 |
| Schizophrenia | 1 |
| Venous Thrombosis | 1 |
| Pulmonary Embolism | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Employment agencies in the United States](https://specstream.ai/data/businesses/employment-agencies/united-states)
- [Concierge medicine practices in the United States](https://specstream.ai/data/businesses/concierge-medicine-practices/united-states)
- [Bottled water companies in the United States](https://specstream.ai/data/businesses/bottled-water-companies/united-states)
- [Audiology clinics in the United States](https://specstream.ai/data/businesses/audiology-clinics/united-states)
- [Walk-in clinics in the United States](https://specstream.ai/data/businesses/walk-in-clinics/united-states)
- [Stone and masonry companies in the United States](https://specstream.ai/data/businesses/stone-and-masonry-companies/united-states)
